VHL and nonpapillary renal cell carcinoma: VHL mutations are early molecular events in ccRCC and result in the stabilization of hypoxia-inducible factors HIF-1α and HIF-1β, creating a pseudohypoxic state that promotes glycolysis and enhances fatty acid and glycogen biosynthesis.